Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resistance between ethnic Chinese, Malays and Asian Indians

International Journal of Obesity

Volumn 36, Issue 8, 2012, Pages 1086-1093

  Gao, H ^a,b   Salim, A ^a   Lee, J ^a   Tai, E S ^a,c,d   Van Dam, R M ^a,c,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c Dept Medicine Endocrinol Diabet   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

adiponectin; adiposity; C reactive protein; ethnicity; insulin resistance; path analysis

Indexed keywords

ADIPONECTIN; ALCOHOL; C REACTIVE PROTEIN; INSULIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INDIAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; WAIST CIRCUMFERENCE;

ADIPONECTIN; ASIAN CONTINENTAL ANCESTRY GROUP; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; CHINA; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOMEOSTASIS; HUMANS; INDIA; INFLAMMATION; INSULIN RESISTANCE; MALAYSIA; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SINGAPORE; WAIST CIRCUMFERENCE; WEIGHT GAIN;

EID: 84864676509     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.185     Document Type: Article

References (48)

1. International Diabetes Federation. IDF Diabetes Atlas. International Diabetes Federation: Brussels, Belgium, 2009.
2. Bhalla V, Fong CW, ChewSK,Satku K. Changes in the levels ofmajorcardiovascular riskfactors in the multi-ethnic population in Singapore after 12 years of a national non-communicable disease intervention programme. Singapore Med J 2006; 47: 841-850. (Pubitemid 44519176)
3. Mente A, Razak F, Blankenberg S, Vuksan V, Davis AD, Miller R et al. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010; 33: 1629-1634.
4. Martin M, Palaniappan LP, Kwan AC, Reaven GM, Reaven PD. Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women. Diabetes Care 2008; 31: 798-801.
5. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health 1997; 51: 394-399. (Pubitemid 27399528)
6. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386.
7. Deurenberg-Yap M, Schmidt G, van Staveren WA, Deurenberg P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord 2000; 24: 1011-1017. (Pubitemid 30618121)
8. Esteve E, Ricart W, Fernandez-Real JM. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 2009; 32 (Suppl 2): S362-S367.
9. Li S, Shin HJ, Ding EL,van Dam RM. Adiponectin levels and riskoftype 2 diabetes: a systematic review and meta-analysis. JAMA 2009; 302: 179-188.
10. Ndumele CE, Pradhan AD, Ridker PM. Interrelationships between inflammation, C-reactive protein, and insulin resistance. J Cardiometab Syndr 2006; 1: 190-196.
11. Misra A. C-reactive protein in young individuals: problems and implications for Asian Indians. Nutrition (Burbank, Los Angeles County, CA) 2004; 20: 478-481. (Pubitemid 38501804)
12. Chambers JC, KoonerJS. Diabetes, insulin resistance and vascular disease among Indian Asians and Europeans. Semin Vasc Med 2002; 2: 199-214.
13. Tan CE, Emmanuel SC, Tan BY, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 1999; 22: 241-247. (Pubitemid 29056917)
14. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 2001; 79: 908-915. (Pubitemid 33027169)
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
16. Gamborg M, Andersen PK, Baker JL, Budtz-Jørgensen E, Jørgensen T, Jensen G et al. Life course path analysis of birth weight, childhood growth, and adult systolic blood pressure. Am J Epidemiol 2009; 169: 1167-1178.
17. Chen W, Srinivasan SR, Berenson GS. Path analysis of metabolic syndrome components in blackversus white children, adolescents, and adults: the Bogalusa Heart Study. Ann Epidemiol 2008; 18: 85-91.
18. Arbuckle JL. Amos (Version 18.0) (Computer Program). SPSS: Chicago, 2007.
19. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2: 367-373. (Pubitemid 44734225)
20. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism Clin Experiment 2003; 52: 1274-1278. (Pubitemid 37351094)
21. Kwon K, Jung SH, Choi C, Park SH. Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women. Int J Cardiol 2005; 101:385-390. (Pubitemid 40719974)
22. Fujikawa R, Ito C, Nakashima R, Orita Y, Ohashi N. Is there any association between subcutaneous adipose tissue area and plasma total and high molecular weight adiponectin levels? Metabolism 2008; 57: 506-510. (Pubitemid 351317965)
23. Nakamura Y, Sekikawa A, Kadowaki T, Kadota A, Kadowaki S, Maegawa H et al. Visceral and subcutaneous adiposity and adiponectin in middle-aged Japanese men: the ERA JUMP study. Obesity (Silver Spring, MD) 2009; 17: 1269-1273.
24. Raji A, Gerhard-Herman MD, Warren M, Silverman SG, Raptopoulos V, Mantzoros CS et al. Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. J Clin Endocrinol Metab 2004; 89: 3965-3972. (Pubitemid 39071500)
25. Chiu KC, Cohan P, Lee NP, Chuang LM. Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function. Diabetes Care 2000; 23: 1353-1358.
26. Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res 2005; 37: 695-701. (Pubitemid 41810493)
27. Lear SA, Kohli S, Bondy GP, Tchernof A, Sniderman AD. Ethnic variation in fat and lean body mass and the association with insulin resistance.JClin EndocrinolMetab 2009; 94: 4696-4702.
28. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386.
29. Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men.JClin EndocrinolMetab 2004; 89: 2750-2755. (Pubitemid 38766361)
30. Chandalia M, Cabo-Chan Jr AV, Devaraj S, Jialal I, Grundy SM, Abate N. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab 2003; 88: 3773-3776. (Pubitemid 37034527)
31. Chandalia M, Lin P, Seenivasan T, Livingston EH, Snell PG, Grundy SM et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS One 2007; 2: e812.
32. Raji A, Gerhard-Herman MD, Williams JS, O'connor ME, Simonson DC Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflam-matory markers in insulin-resistant non-diabetic Asian Indians. Diabet Med 2006; 23: 537-543.
33. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta-analysis among different ethnic groups. IntJObes RelatMetab Disord 1998; 22: 1164-1171. (Pubitemid 28548536)
34. Ehtisham S, Crabtree N, Clark P, Shaw N, Barrett T. Ethnic differences in insulin resistance and body composition in United Kingdom adolescents. J Clin Endocrinol Metab 2005; 90: 3963-3969. (Pubitemid 41058158)
35. Raji A, Seely EW, Arky RA, Simonson DC Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001; 86: 5366-5371. (Pubitemid 33070261)
36. Valsamakis G, Chetty R, McTernan PG, Al-Daghri NM, Barnett AH, Kumar S. Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol. Diabetes Obesity Metabolism 2003; 5: 131-135. (Pubitemid 36372506)
37. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001; 104: 145-150. (Pubitemid 32655829)
38. Krishnaveni GV, Hill JC, Veena SR, Bhat DS, Wills AK, Karat CL et al. Low plasma vitamin B12 in pregnancy is associated with gestational 'diabesity' and later diabetes. Diabetologia 2009; 52: 2350-2358.
39. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008; 51: 29-38. (Pubitemid 350197985)
40. Torrens JI, Skurnick J, Davidow AL, Korenman SG, Santoro N, Soto-Greene M et al. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 2004; 27: 354-361. (Pubitemid 38174057)
41. Chiu KC, Chuang LM, Yoon C. Comparison of measured and estimated indices of insulin sensitivity and beta cell function: impact of ethnicity on insulin sensitivity and beta cell function in glucose-tolerant and normotensive subjects. J Clin Endocrinol Metab 2001; 86: 1620-1625. (Pubitemid 32374914)
42. LeeJW, Brancati FL, Yeh HC. Trends in the prevalence ofType 2 diabetes in asians versus whites: results from the United States National Health Interview Survey, 1997-2008. Diabetes Care 2011; 34: 353-357.
43. Kadowaki T, Sekikawa A, Okamura T, Takamiya T, Kashiwagi A, Zaky WR et al. Higher levels of adiponectin in American than in Japanese men despite obesity. Metabolism 2006; 55: 1561-1563. (Pubitemid 44827132)
44. Lee S, Jensen MD. Adipogenic riskfactor differences between Korean and white adults-potential role of plasma free fatty acid and adiponectin. Metabolism 2009; 58: 270-274.
45. Dans A, Ng N, Varghese C, Tai ES, Firestone R, Bonita R. The rise of chronic non-communicable diseases in southeast Asia: time for action. Lancet 2011; 377: 680-689.
46. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001; 24: 362-365. (Pubitemid 32119139)
47. Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD. Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. IntJObes RelatMetab Disord2003; 27: 784-789. (Pubitemid 36819534)
48. Menzaghi C, Trischitta V, Doria A. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 2007; 56: 1198-1209. (Pubitemid 46715598)